RECOVERY Trial

RECOVERY: Randomized Evaluation of COVID-19 Therapy
RECOVERY Trial logo

The Randomised Evaluation of COVID-19 Therapy (RECOVERY Trial)[1] is a large-enrollment clinical trial of possible treatments for people in the United Kingdom admitted to hospital with severe COVID-19 infection.[2][3][4] The trial was later expanded to Indonesia, Nepal and Vietnam.[5] The trial has tested ten interventions on adults: eight repurposed drugs, one newly developed drug and convalescent plasma.[2]

  1. ^ "ISRCTN - ISRCTN50189673: A randomised trial of treatments to prevent death in patients hospitalised with COVID-19 (coronavirus)". www.isrctn.com.
  2. ^ a b "RECOVERY Trial". Retrieved 17 June 2020.
  3. ^ "Coronavirus: Dexamethasone being used to treat NHS patients today". BBC News. 17 June 2020. Retrieved 17 June 2020.
  4. ^ "Biggest COVID-19 trial tests repurposed drugs first". Nature Biotechnology. 38 (5): 510. 11 May 2020. doi:10.1038/s41587-020-0528-x. PMID 32393915. S2CID 218593584.
  5. ^ "International sites — RECOVERY Trial". www.recoverytrial.net. Retrieved 17 May 2021.

Developed by StudentB